These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19685394)

  • 21. [Clinical aspects of botulism in cattle].
    Hofmann W
    Dtsch Tierarztl Wochenschr; 1999 Feb; 106(2):74. PubMed ID: 10085585
    [No Abstract]   [Full Text] [Related]  

  • 22. [From botulism to cosmetics--a story of a drug].
    Aquilonius SM
    Lakartidningen; 2000 Mar; 97(11):1228-31. PubMed ID: 10771540
    [No Abstract]   [Full Text] [Related]  

  • 23. Learning from the past: historical aspects of bacterial toxins as pharmaceuticals.
    Pellett S
    Curr Opin Microbiol; 2012 Jun; 15(3):292-9. PubMed ID: 22651975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Botulinum toxin--the dose controls the poison. A historical sketch].
    Homann CN; Wenzel K; Kriechbaum N; Suppan K; Crevenna R; Ivanic G; Dressler D
    Nervenarzt; 2002 Jun; 73(6):519-24. PubMed ID: 12242998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin: from poison to pharmaceutical. The history of a poison that became useful to mankind.
    Kreyden OP
    Curr Probl Dermatol; 2002; 30():94-100. PubMed ID: 12471702
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of enzyme-linked immunoassays for antibody to types C and D botulinum toxins for investigations of botulism in cattle.
    Gregory AR; Ellis TM; Jubb TF; Nickels RJ; Cousins DV
    Aust Vet J; 1996 Feb; 73(2):55-61. PubMed ID: 8660200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin in painful tardive dyskinesia.
    Tschopp L; Salazar Z; Micheli F
    Clin Neuropharmacol; 2009; 32(3):165-6. PubMed ID: 19483486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulism in an Oregon dairy cow herd.
    Gray TC; Bulgin MS
    J Am Vet Med Assoc; 1982 Jan; 180(2):160-2. PubMed ID: 7061313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin: clinical use.
    Truong DD; Jost WH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin as a treatment for tardive dyskinesia.
    van Harten PN; Hovestadt A
    Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin and the eye.
    Marsh IB
    Hosp Med; 2003 Aug; 64(8):464-7. PubMed ID: 12958757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin, Quo Vadis?
    Lim EC; Seet RC
    Med Hypotheses; 2007; 69(4):718-23. PubMed ID: 17499937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulinum toxin: from poison to drug. A historical review].
    Kreyden OP; Geiges ML; Böni R; Burg G
    Hautarzt; 2000 Oct; 51(10):733-7. PubMed ID: 11153358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin injections to treat belly dancer's dyskinesia.
    Lim EC; Seet RC
    Mov Disord; 2009 Jul; 24(9):1401. PubMed ID: 19373937
    [No Abstract]   [Full Text] [Related]  

  • 35. Application of PCR for detection of Clostridium botulinum type D in bovine samples.
    Chaffer M; Baum M; Grinberg K; Molad T; Elad D
    J Vet Med B Infect Dis Vet Public Health; 2006 Feb; 53(1):45-7. PubMed ID: 16460356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc.
    Dressler D; Hallett M
    Eur J Neurol; 2006 Feb; 13 Suppl 1():11-5. PubMed ID: 16417592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin. From poison to medicine.
    Davis LE
    West J Med; 1993 Jan; 158(1):25-9. PubMed ID: 8470380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin useful against writer's cramp].
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of botulinum toxin in the treatment of refractory overactive bladder.
    Mucksavage P; Smith AL; Moy ML
    Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700
    [No Abstract]   [Full Text] [Related]  

  • 40. Botulinum toxin: mechanisms of action.
    Dressler D; Saberi FA; Barbosa ER
    Arq Neuropsiquiatr; 2005 Mar; 63(1):180-5. PubMed ID: 15830090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.